Dow Jones
38 383,49 -120,20 (-0,31 %) Nasdaq
15 657,27 -39,37 (-0,25 %) Nikkei 225
38 460,08 +907,92 (+2,42 %) EUR/USD
1,0692 -0,0013 (-0,12 %) HANG SENG
17 201,27 +372,34 (+2,21 %) Bitcoin EUR
60 477,94 -1 948,23 (-3,12 %)
Smith & Nephew plc (SN.L)
Smith & Nephew plc
Building 5
Croxley Park Hatters Lane
Watford WD18 8YE
United Kingdom
44 1923 477 100
https://www.smith-nephew.com
Secteur(s): Healthcare
Secteur d’activité: Medical Devices
Employés à temps plein: 18 452
Dirigeants clés
| Nom | Titre | Payer | Exercé | Année de naissance |
|---|---|---|---|---|
| Dr. Deepak S. Nath Ph.D. | CEO & Director | 3,77M | S.O. | 1972 |
| Mr. John Terence Rogers | CFO & Executive Director | S.O. | S.O. | 1969 |
| Mr. Paul Connolly | President of Global Operations | S.O. | S.O. | 1968 |
| Mr. Andrew Swift | Vice President of Investor Relations | S.O. | S.O. | S.O. |
| Ms. Helen Barraclough | Group General Counsel & Company Secretary | S.O. | S.O. | 1979 |
| Ms. Alison Parkes | Chief Compliance Officer & Compliance APAC | S.O. | S.O. | 1972 |
| Mr. Joe Metzger | Senior Vice President of Marketing Services & Communications | S.O. | S.O. | S.O. |
| Mr. Philip G. Cowdy | Chief Corporate Development & Corporate Affairs Officer | S.O. | S.O. | 1967 |
| Ms. Elga Lohler | Chief Human Resources Officer | S.O. | S.O. | 1968 |
| Dr. Vasant Padmanabhan Ph.D. | President of Research & Development and Ear, Nose & Throat | S.O. | S.O. | 1967 |
Description
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Gouvernance d’entreprise
L’ISS Governance QualityScore de Smith & Nephew plc en date du 1 avril 2024 est 4. Les scores principaux sont Audit : 8; Société : 2; Droits des actionnaires : 1; Compensation : 7.
